Drug approval.Drug Approval: Abraxis BioScience Inc. said that the European Medicines Agency The European Medicines Agency (EMEA) is a European agency for the evaluation of medicinal products. Until 2004, the European Medicines Agency was known as The European Agency for the Evaluation of Medicinal Products. Roughly parallel to the U.S. has accepted the company's application to market its Abraxane drug for the treatment of breast cancer. Abraxane was approved in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. in 2005 and in Canada this June. The Los Angeles-based biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. company also said that it plans to file for regulatory approval in China, Japan, Korea, Taiwan, Australia, Turkey and Russia, among other countries. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion